Haemonetics Corporation (HAE)
Create an Alert
42.35
-0.36 -0.84%
NYSE
Jun 19, 8:00PM
BATS Real time
Currency in USD
Haemonetics Corporation Revenue Quarterly YoY Growth:
33.90% for Dec. 31, 2012Haemonetics Corporation Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 33.90% |
| Dec. 31, 2012 | 29.42% |
| Sept. 30, 2012 | 21.58% |
| June 30, 2012 | 3.46% |
| March 31, 2012 | 9.78% |
| Dec. 31, 2011 | 8.13% |
| Sept. 30, 2011 | 7.56% |
| June 30, 2011 | 4.62% |
| March 31, 2011 | 0.55% |
| Dec. 31, 2010 | 7.04% |
| Sept. 30, 2010 | 6.22% |
| June 30, 2010 | 5.81% |
| March 31, 2010 | 10.96% |
| Dec. 31, 2009 | 6.25% |
| Sept. 30, 2009 | 7.64% |
| June 30, 2009 | 6.92% |
| March 31, 2009 | 9.84% |
| Dec. 31, 2008 | 15.50% |
| Sept. 30, 2008 | 20.42% |
| June 30, 2008 | 18.19% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
HAE Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Conceptus | 17.50% |
| Myriad Genetics | 20.57% |
| Cyberonics | 18.63% |
HAE Revenue Quarterly YoY Growth Rankings
| Overall |
93rd percentile 1045 of 16782 |
| Sector |
88th percentile 160 of 1410 in Healthcare |
| Industry |
90th percentile 15 of 152 in Medical Instruments & Supplies |
HAE Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | 0.55% | Mar 2011 |
| Maximum | 33.90% | Mar 2013 |
| Average | 11.69% |
